Condensed Consolidated Statements of Stockholders Equity (Unaudited) - USD ($)
|
Total |
Additional Paid-in Capital [Member] |
Accumulated Other Comprehensive Income (Loss) [Member] |
Accumulated Deficit [Member] |
Non Controlling Interest [Member] |
Common stock [Member] |
Balance, shares at Dec. 31, 2018 |
|
|
|
|
|
35,335,378
|
Balance, amount at Dec. 31, 2018 |
$ 12,140,456
|
$ 85,604,271
|
$ 223,651
|
$ (73,722,801)
|
$ 0
|
$ 35,335
|
Common stock issued in exercise of warrants, shares |
|
|
|
|
|
2,478,613
|
Common stock issued in exercise of warrants, amount |
6,660,671
|
6,658,192
|
0
|
0
|
0
|
$ 2,479
|
Stock-based compensation |
340,458
|
340,458
|
0
|
0
|
0
|
0
|
Modification of financing warrants |
196,957
|
196,957
|
0
|
0
|
0
|
0
|
Foreign currency translation |
(24,054)
|
0
|
(24,054)
|
0
|
|
0
|
Net loss for the period |
(4,203,773)
|
0
|
0
|
(4,203,773)
|
0
|
$ 0
|
Balance, shares at Mar. 31, 2019 |
|
|
|
|
|
37,813,991
|
Balance, amount at Mar. 31, 2019 |
15,110,715
|
92,799,878
|
199,597
|
(77,926,574)
|
0
|
$ 37,814
|
Balance, shares at Dec. 31, 2018 |
|
|
|
|
|
35,335,378
|
Balance, amount at Dec. 31, 2018 |
12,140,456
|
85,604,271
|
223,651
|
(73,722,801)
|
0
|
$ 35,335
|
Net loss for the period |
(12,541,749)
|
|
|
|
|
|
Balance, shares at Sep. 30, 2019 |
|
|
|
|
|
41,092,340
|
Balance, amount at Sep. 30, 2019 |
17,801,780
|
103,374,419
|
650,819
|
(86,264,550)
|
0
|
$ 41,092
|
Balance, shares at Mar. 31, 2019 |
|
|
|
|
|
37,813,991
|
Balance, amount at Mar. 31, 2019 |
15,110,715
|
92,799,878
|
199,597
|
(77,926,574)
|
0
|
$ 37,814
|
Common stock issued in exercise of warrants, shares |
|
|
|
|
|
1,666,667
|
Common stock issued in exercise of warrants, amount |
5,000,001
|
4,998,334
|
0
|
0
|
0
|
$ 1,667
|
Stock-based compensation |
379,507
|
379,507
|
0
|
0
|
0
|
0
|
Foreign currency translation |
49,913
|
0
|
49,913
|
0
|
0
|
0
|
Net loss for the period |
(4,157,171)
|
0
|
0
|
(4,157,171)
|
0
|
$ 0
|
Balance, shares at Jun. 30, 2019 |
|
|
|
|
|
39,480,658
|
Balance, amount at Jun. 30, 2019 |
16,382,965
|
98,177,719
|
249,510
|
(82,083,745)
|
0
|
$ 39,481
|
Common stock issued in exercise of warrants, shares |
|
|
|
|
|
1,609,195
|
Common stock issued in exercise of warrants, amount |
4,827,585
|
4,825,976
|
0
|
0
|
0
|
$ 1,609
|
Stock-based compensation |
370,726
|
370,726
|
0
|
0
|
0
|
0
|
Foreign currency translation |
401,309
|
0
|
401,309
|
0
|
0
|
0
|
Net loss for the period |
(4,180,805)
|
0
|
0
|
(4,180,805)
|
0
|
$ 0
|
Common stock issued in exercise of stock options, shares |
|
|
|
|
|
2,487
|
Common stock issued in exercise of stock options, amount |
0
|
(2)
|
0
|
0
|
0
|
$ 2
|
Balance, shares at Sep. 30, 2019 |
|
|
|
|
|
41,092,340
|
Balance, amount at Sep. 30, 2019 |
17,801,780
|
103,374,419
|
650,819
|
(86,264,550)
|
0
|
$ 41,092
|
Balance, shares at Dec. 31, 2019 |
|
|
|
|
|
41,125,303
|
Balance, amount at Dec. 31, 2019 |
14,198,566
|
103,853,627
|
125,670
|
(89,821,856)
|
0
|
$ 41,125
|
Stock-based compensation |
192,669
|
192,669
|
0
|
0
|
0
|
0
|
Foreign currency translation |
373,926
|
0
|
373,926
|
0
|
0
|
0
|
Net loss for the period |
(5,859,339)
|
0
|
0
|
(5,849,772)
|
(9,567)
|
$ 0
|
Common stock issued in exercise of stock options, shares |
|
|
|
|
|
19,430
|
Common stock issued in exercise of stock options, amount |
0
|
(20)
|
0
|
0
|
0
|
$ 20
|
Common stock issued for Director compensation in Volition Germany, shares |
|
|
|
|
|
73,263
|
Common stock issued for Director compensation in Volition Germany, amount |
333,969
|
333,896
|
0
|
0
|
0
|
$ 73
|
Common stock repurchase and retirement, shares |
|
|
|
|
|
(11,364)
|
Common stock repurchase and retirement, amount |
(54,434)
|
(54,423)
|
0
|
0
|
0
|
$ (11)
|
Balance, shares at Mar. 31, 2020 |
|
|
|
|
|
41,206,632
|
Balance, amount at Mar. 31, 2020 |
9,185,357
|
104,325,749
|
499,596
|
(95,671,628)
|
(9,567)
|
$ 41,207
|
Balance, shares at Dec. 31, 2019 |
|
|
|
|
|
41,125,303
|
Balance, amount at Dec. 31, 2019 |
14,198,566
|
103,853,627
|
125,670
|
(89,821,856)
|
0
|
$ 41,125
|
Net loss for the period |
(15,238,380)
|
|
|
|
|
|
Balance, shares at Sep. 30, 2020 |
|
|
|
|
|
48,064,575
|
Balance, amount at Sep. 30, 2020 |
18,961,411
|
124,121,703
|
(148,121)
|
(105,036,840)
|
(23,396)
|
$ 48,065
|
Balance, shares at Mar. 31, 2020 |
|
|
|
|
|
41,206,632
|
Balance, amount at Mar. 31, 2020 |
9,185,357
|
104,325,749
|
499,596
|
(95,671,628)
|
(9,567)
|
$ 41,207
|
Stock-based compensation |
360,640
|
360,640
|
0
|
0
|
0
|
0
|
Foreign currency translation |
(74,320)
|
0
|
(74,320)
|
0
|
0
|
0
|
Net loss for the period |
(5,043,093)
|
0
|
0
|
(5,037,314)
|
(5,779)
|
$ 0
|
Common stock issued in public offering, net, shares |
|
|
|
|
|
5,452,922
|
Common stock issued in public offering, net, amount |
14,234,613
|
14,229,160
|
0
|
0
|
0
|
$ 5,453
|
Balance, shares at Jun. 30, 2020 |
|
|
|
|
|
46,659,554
|
Balance, amount at Jun. 30, 2020 |
18,663,197
|
118,915,549
|
425,276
|
(100,708,942)
|
(15,346)
|
$ 46,660
|
Common stock issued in exercise of warrants, shares |
|
|
|
|
|
25,000
|
Common stock issued in exercise of warrants, amount |
61,750
|
61,725
|
0
|
0
|
0
|
$ 25
|
Stock-based compensation |
428,683
|
428,683
|
0
|
0
|
0
|
0
|
Foreign currency translation |
(573,397)
|
0
|
(573,397)
|
0
|
0
|
0
|
Net loss for the period |
(4,335,948)
|
0
|
0
|
(4,327,898)
|
(8,050)
|
$ 0
|
Common stock issued in exercise of stock options, shares |
|
|
|
|
|
127,838
|
Common stock issued in exercise of stock options, amount |
82,500
|
82,372
|
0
|
0
|
0
|
$ 128
|
Common stock issued in public offering, net, shares |
|
|
|
|
|
1,252,183
|
Common stock issued in public offering, net, amount |
4,822,091
|
4,820,839
|
0
|
0
|
0
|
$ 1,252
|
Tax withholdings paid related to stock-based compensation |
(187,465)
|
(187,465)
|
0
|
0
|
0
|
$ 0
|
Balance, shares at Sep. 30, 2020 |
|
|
|
|
|
48,064,575
|
Balance, amount at Sep. 30, 2020 |
$ 18,961,411
|
$ 124,121,703
|
$ (148,121)
|
$ (105,036,840)
|
$ (23,396)
|
$ 48,065
|